Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of MP03-36 in Subjects With Seasonal Allergic Rhinitis

NCT00660829 is registered in ClinicalTrials.gov with Meda Pharmaceuticals as lead sponsor.

NCT NCT00660829
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00660829 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of MP03-36 in Subjects With Seasonal Allergic Rhinitis
Lead sponsor
Meda Pharmaceuticals
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2007
Completion date
April 30, 2008
Enrollment
536 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

seasonal allergic rhinitis